Phibro Animal Health Corporatio — Earnings Quality Grade F
PAHC · Healthcare
Major red flags
Screening Summary
管理层信号
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 64 days, change +3 days YoY
AR growth 34.5% vs revenue growth 27.4%
Revenue grew 27.4% but CFFO declined -8.5%
Expense Quality
Inventory growth 67.1% exceeds COGS 27.2%
CapEx growth -7.1% vs revenue 27.4%. Normal
SG&A/Gross Profit = 72.4%, exceeds 70%
Gross margin 30.9%, change +0.1pp. Stable
Cash Flow Quality
CFFO/NI = 1.66. Profits backed by cash
FCF $0.0B, FCF/NI = 0.87
Accruals ratio = -2.3%. Low accruals
Cash $0.1B covers only 10% of debt $0.8B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 34% of equity
Debt/EBITDA = 5.2x (>4x). Financial stress
Other assets grew 146.9% vs revenue 27.4%
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles change -3% YoY. Normal
Manipulation Score
M-Score = -2.35 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25